180 WEALTH ADVISORS, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 66 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
180 WEALTH ADVISORS, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$26,000
-25.7%
25,0000.0%0.01%
-31.2%
Q2 2019$35,000
-18.6%
25,0000.0%0.02%
-20.0%
Q1 2019$43,000
-46.9%
25,000
-16.7%
0.02%
-47.4%
Q4 2018$81,0000.0%30,0000.0%0.04%
+2.7%
Q3 2018$81,000
+42.1%
30,0000.0%0.04%
+32.1%
Q2 2018$57,000
+35.7%
30,000
+50.0%
0.03%
+27.3%
Q1 2018$42,00020,0000.02%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$29,094,0002.84%
EcoR1 Capital, LLC 412,000$787,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 1,130,432$2,159,0000.05%
ESSEX INVESTMENT MANAGEMENT CO LLC 164,605$314,0000.04%
Clear Harbor Asset Management, LLC 95,630$183,0000.03%
ALGERT GLOBAL LLC 72,556$139,0000.03%
180 WEALTH ADVISORS, LLC 30,000$57,0000.03%
GSA CAPITAL PARTNERS LLP 289,854$554,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 85,412$163,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$877,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders